The content on this site is intended for healthcare professionals only
Dr Emiel J. Rutgers presents data on a European phase III clinical trial called AMAROS at the 2013 ASCO Annual Meeting in Chicago.
The study found that axillary radiotherapy (ART) and lymph node surgery (axillary lymph node dissection, ALND) resulted in equivalent overall and disease-free survival at five years after treatment for women with sentinel lymph node positive early breast cancer. However, a debilitating side effect known as lymphoedema was twice as common among women who underwent surgery.
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
Rationale for routine use of IORT for early breast cancer and data for specific indications
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
Neo-adjuvant therapy for different cancers in the Philippines
The pros and cons of breast IORT and ultra hypofractionation (FR)
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
